BIOGEN PHARMACHEM INDUSTRIES L

BSE: 531752 09 Sep 2025

Financial Services

₹ 0.9

BIOGEN PHARMACHEM INDUSTRIES LIMITED specializes in Other Financial Services within the Financial Services sector.

BIOGEN PHARMACHEM INDUSTRIES L

BSE: 531752 09 Sep 2025

Financial Services

₹ 0.9

BIOGEN PHARMACHEM INDUSTRIES LIMITED specializes in Other Financial Services within the Financial Services sector.

Book Value

1.41

Dividend Yield

0.0%

Debt to Equity

0.0

Stock P/E

65.6

Market Cap

79.4 Cr

BIOGEN PHARMACHEM INDUSTRIES L - Share Price & Details

Market Cap

₹79.4

High /Low

1.38 / 0.75

Stock P/E

65.6

Book Value

₹1.41

Dividend Yield

0.0

ROCE

-0.39

ROE

₹-0.39

Face Value

1.0

PEG Ratio

EVEBITDA

₹64.0

Debt

0.00

CMP / FCF

93.1

Debt to equity

₹0.0

NP Ann

-0.29

High price all time

4.2

Piotroski score

₹3.0

Graham Number

0.64

No. Eq. Shares

90.3

Net CF

₹2.00

Net profit

1.21

Price to book value

0.62

Interest Coverage

₹NA

Low price all time

0.04

Industry PE

35.6

Reserves

₹26.7

Free Cash Flow

₹-1.08

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
Satyam Silk Mills Ltd	NA	NA	NA	NA	0
Shikhar Leasing and Trading Ltd.	NA	NA	NA	NA	0
BIOGEN PHARMACHEM INDUSTRIES L	NA	NA	NA	NA	79.4	65.6
Srestha Finvest Limited	NA	NA	NA	NA	78.7
WSFX Global Pay Limited	NA	NA	NA	NA	77.4	29.9

Peer Comparison Chart

About BIOGEN PHARMACHEM INDUSTRIES L

BIOGEN PHARMACHEM INDUSTRIES LIMITED, with Security Code 531752, is a leading player in the Other Financial Services industry, categorized under the Financial Services sector, offering Equity instruments.

Latest News

biogen pharmachem industries reports standalone net profit of rs 1 34 crore in the june 2025 quarter

(16 Aug 2025)

Net profit of Biogen Pharmachem Industries reported to Rs 1.34 crore in the quarter ended June 2025 as against net loss of Rs 0.16 crore during the pr...

Biogen Pharmachem Industries Faces Mixed Financial Outlook Amid Recent Performance Gains

(12 Aug 2025)

Biogen Pharmachem Industries has recently adjusted its evaluation due to shifts in financial metrics and market position. The company has reported...

Biogen Pharmachem Industries Limited (531752) Stock Experiences Sudden Dip - Superior trading gains

(04 Aug 2025)

Biogen Pharmachem Industries Limited (531752) Stock Experiences Sudden Dip ✌️【Market Focus】✌️ Experience smarter investing with...

Macro Trends and Their Impact on Biogen Pharmachem Industries Limited (531752) - Harness the power of proven investment plans

(04 Aug 2025)

【Stock Buzz】✌️ Unlock access to high-performance portfolios that have outpaced the market with 2x–3x growth in under a year.

Biogen Pharmachem Industries Limited (531752) Sees Unusual Trading Volume - Unlock expert insights for smarter investing

(03 Aug 2025)

Biogen Pharmachem Industries Limited (531752) Sees Unusual Trading Volume ✌️【Investment Insights】✌️ Professional-grade analytics and free...

Biogen Pharmachem Industries Reports Strong Financial Results, Indicating Positive Growth Trajectory

(31 Jul 2025)

Biogen Pharmachem Industries has announced its financial results for the quarter ending March 2025, showcasing significant improvements.

Quarterly Table

Standalone

Metrics	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	0.0	0.0	0.8	0.0	0.0	0.0	-0.1	0.0	0.0	1.4
Expenses	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.3	0.5	0.1
Operating Profit	0.0	-0.2	0.4	0.0	0.0	0.0	-0.2	-0.3	-0.5	1.3
OPM %	0%	1970%	54.05%	0%	0%	0%	173.63%	0%	0%	92.6%
Other Income	0.3	0.0	0.0	0.8	0.1	0.8	0.0	-0.7	0.2	0.0
Interest	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Depreciation	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Profit before tax	0.3	-0.2	0.4	0.7	0.1	0.7	-0.2	-1.0	-0.3	1.3
Tax %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Profit	0.3	-0.2	0.4	0.7	0.1	0.7	-0.2	-1.0	-0.3	1.2
EPS in Rs			0.01	0.01		0.01		-0.02		0

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	0%
5 Years:	-4%
3 Years:	-21%
TTM:	-7%

Compounded Profit Growth
10 Years:	17%
5 Years:	0%
3 Years:	30%
TTM:	-174%

Stock Price CAGR
10 Years:	14%
5 Years:	40%
3 Years:	-3%
1 Year:	-9%

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Stock Price CAGR
10 Years:	0%
5 Years:	0%
3 Years:	0%
1 Year:	0%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

Stock Mutual Funds Data

Loading technicals…

Moving Averages

Latest Close: — • Records Used: — • Last Trading Date: —

Simple Moving Averages (SMA)

Period	SMA Value	Status

Exponential Moving Averages (EMA)

Period	EMA Value	Status

Oscillators

Key Oscillators

latest calculation

Indicator	Value

BIOGEN PHARMACHEM INDUSTRIES L

BIOGEN PHARMACHEM INDUSTRIES L

BIOGEN PHARMACHEM INDUSTRIES L - Share Price & Details

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About BIOGEN PHARMACHEM INDUSTRIES L

Latest News

biogen pharmachem industries reports standalone net profit of rs 1 34 crore in the june 2025 quarter

Biogen Pharmachem Industries Faces Mixed Financial Outlook Amid Recent Performance Gains

Biogen Pharmachem Industries Limited (531752) Stock Experiences Sudden Dip - Superior trading gains

Macro Trends and Their Impact on Biogen Pharmachem Industries Limited (531752) - Harness the power of proven investment plans

Biogen Pharmachem Industries Limited (531752) Sees Unusual Trading Volume - Unlock expert insights for smarter investing

Biogen Pharmachem Industries Reports Strong Financial Results, Indicating Positive Growth Trajectory

Will MET.PRA stock benefit from AI tech trends - Rapidly expanding wealth

Q1 results: Infosys, Tata Consumer Products, Dr Reddy's, Bajaj Housing Finance, Bikaji Foods, others to post earnings on July 23; check list

Biogen Pharmachem Industries Faces Mixed Performance Amid Shifting Market Sentiment

Biogen Pharmachem Industries Limited (531752) Quarterly Results Are Out - Unprecedented market success

Biogen Pharmachem Industries Limited (531752)’s Trend in 2025 - Record-setting profit potential

Biogen Pharmachem Industries to convene board meeting

Biogen Pharmachem Industries reports standalone net profit of Rs 1.34 crore in the June 2025 quarter

What analysts say about VEEE stock - Superior return velocity

Biogen Pharmach Standalone June 2025 Net Sales at Rs 1.54 crore, up 1797.25% Y-o-Y

Q1 Results Today: Bajaj Housing Finance, Infosys, Dr Reddys Among 60 Companies To Declare Earnings

Vaxtex Cotfab reports standalone net profit of Rs 1.32 crore in the March 2025 quarter

BIOGEN PHARMACHEM INDUSTRIES TO CONVENE BOARD MEETING

Biogen Pharmachem Industries standalone net profit rises 59.46% in the March 2025 quarter

Sheshadri Industries reports standalone net profit of Rs 6.13 crore in the March 2025 quarter

Johnson Pharmacare reports standalone net loss of Rs 0.51 crore in the March 2025 quarter

Balkrishna Industries consolidated net profit declines 24.28% in the March 2025 quarter

Q4 Results 2025 Today: Ashok Leyland, BEML, JSW Steel Among 200+ Companies To Declare Earnings On May 23

Q4 results: Bharat Electronics, DLF, IRB Infra, Jupiter Wagons, Indigo, IndusInd Bank, EIH Hotels, Power Grid among 700 companies to announce results this week

Stock market today: NIFTY50 crosses 25,000 for first time in seven months, here's why

Birla Cable, Incredible Industries, HBL Engineering, Indus Towers: Stocks that are seeing spurt in volumes today

Q4 results: HCL Technologies, Waaree Energies, Havells India among firms to post earnings on April 22; check list

Biogen Pharmachem Industries reports standalone net loss of Rs 0.31 crore in the December 2024 quarter

JSW Group to Invest ₹3 Lakh Crore in Maharashtra; Check the list of stocks

Q4 Results Today: Aurobindo Pharma, Reliance Power, Divi's Lab among 91 companies to post earnings on May 25

NBCC, Deepak Nitrite, Eicher Motors, Patel Engineering Among 650+ Companies To Declare Q2 Results Today

650 Companies To Declare Q2 Results, Including Godrej Industries, Eicher Motors, AstraZeneca & Garden Reach

650 Companies To Declare Q2 Results, Including Godrej Industries, Eicher Motors, AstraZeneca & Garden Reach Shipbuilders

Stocks Under Rs 5 – List of Best Undervalued Shares under 5 Rs.

Top events today: Rahul, Priyanka Gandhi to visit Wayanad; ITC to release Q1 results; Schools closed in Delhi amid rain

Biogen Pharmachem Industries reports standalone net loss of Rs 0.16 crore in the June 2024 quarter

Prataap Snacks standalone net profit declines 29.66% in the June 2024 quarter

Paradeep Phosphates reports consolidated net profit of Rs 5.38 crore in the June 2024 quarter

Top events today: Rahul, Priyanka Gandhi to visit Wayanad; ITC to release Q1 results; Schools closed in Delhi amid rain | Today News

Q1 Results Today: Tata Motors, Adani Ports, ITC, Zomato Among 80+ Firms To Declare Earnings On August 1

Q1 results today: Adani Enterprises, Tata Motors, ITC, Sun Pharma, Zomato, others to post earnings on August 1; check list

Biogen Pharma's Q1 FY25 Financial Report Shows Decline in Performance, Receives 'Sell' Rating

Q1 Results This Week: Adani Power, Zomato, SBI, Tata Motors Among 250+ Firms To Declare Earnings

Q1 Results This Week: Zomato, ITC, Tata Motors, SBI Among 250+ Firms To Declare Earnings

Q1 Results This Week: Delhivery, Infibeam Avenues, Aeroflex Industries Among 130+ Firms To Declare Earnings

Q1 results: SBI, Tata Steel, Coal India, BHEL, Pfizer, and Sun Pharma among companies to declare earnings next week | Stock Market News

Q1 results: SBI, Tata Steel, Coal India, BHEL, Pfizer, and Sun Pharma among companies to declare earnings next week

Top 10 Penny Stocks in 2024

Kisaan Parivar Industries Share Price Today - Kisaan Parivar Industries Stock Price Live NSE/BSE

Biogen Pharmachem Industries Share Price

Biogen Pharmachem Industries reports standalone net profit of Rs 0.74 crore in the March 2024 quarter

Stock alert: LIC, NTPC, Divis Labs, United Spirits, Indian Oil Corp

Q4 Results Today: Aurobindo Pharma, Reliance Power, Divi's Lab among 91 companies to post earnings on May 25 | Company Business News

Nazara Technologies announces change in promoter shareholding

Q4 Results Today: Aurobindo Pharma, Vadilal Industries Among 90+ Companies To Report Earnings

Quarterly Results Today, 25th May: THESE NSE, BSE companies are set to declare Q4 2024 earnings, dividend – FULL LIST

Biogen Pharmachem Industries Ltd

Medicines

Q3 Results: Yes Bank, Utkarsh Small Finance Bank, Macrotech Developers To Announce Earnings On Jan 27

Biogen Pharmachem Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023

Q3 results this week: L&T Finance, Pidilite Ind, Adani Power, IIFL Securities, Zensar Technologies, Axis Bank and mo | Company Business News

सोमवार को ये 10 शेयर आपको देने वाले हैं झमाझम रिटर्न, दांव लगाना पसंद करेंगे आप!

Watch out for these penny stocks locked in the upper circuit on December 15

Patanjali Foods, Thomas Cook, and MMTC shares rise after price band revision

Merck, Novo Nordisk, Gilead, Biogen and more: Here are the investment opportunities in global Big Pharma

Multi-Bagger Penny Stocks For 2025

Best Multi-bagger Penny Stocks To Watch Out For 2025

Dr Reddy's Laboratories jumps into the fray for Biogen's biosimilars

Intas eyes Biogen’s biosimilars for $1 bn | Company Business News

Intas eyes Biogen’s biosimilars for $1 bn

Biogen Pharmachem Industries Profit & Loss Annual